Vistagen Therapeutics (VTGN) Earnings Date, Estimates & Call Transcripts → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free VTGN Stock Alerts $3.68 -0.11 (-2.90%) (As of 06/10/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryLatest Earnings DateJun. 11ConfirmedConsensus EPS (Jun. 11) -$0.34 Listen to Call Get Vistagen Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for VTGN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVTGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VTGN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Sasco Gold LLCDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is for YOU. 99% of people are buying gold the wrong way.Reserve your seat here. Vistagen Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.10)($0.10)($0.10)Q2 20241($0.08)($0.08)($0.08)Q3 20241($0.28)($0.28)($0.28)Q4 20241($0.27)($0.27)($0.27)FY 20244($0.73)($0.73)($0.73)Q1 20251($0.38)($0.38)($0.38)Q2 20251($0.48)($0.48)($0.48)Q3 20251($0.54)($0.54)($0.54)Q4 20251($0.65)($0.65)($0.65)FY 20254($2.05)($2.05)($2.05)VTGN Earnings Date and InformationVistagen Therapeutics last announced its earnings data on June 11th, 2024. The reported $0.00 earnings per share for the quarter, beating the consensus estimate of ($0.34) by $0.34. Vistagen Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Vistagen Therapeutics are expected to decrease in the coming year, from ($1.56) to ($2.00) per share. Vistagen Therapeutics has confirmed that its next quarterly earnings report will be published on Tuesday, June 11th, 2024. Vistagen Therapeutics will be holding an earnings conference call on Tuesday, June 11th at 5:00 PM Eastern. Interested parties can register for or listen to the call. or dial in at 412-317-6671 with passcode "13746589". Read More Vistagen Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 6/11/2024(Confirmed)-($0.34)----- 2/13/2024Q3 2024($0.31)($0.22)+$0.09($0.22)$0.73 million$0.41 million11/9/2023Q2 2024-($0.66)($0.66)($0.66)-$0.28 million8/10/2023Q1 2024-($0.94)($0.94)($0.94)-$0.18 million2/7/2023Q3 2023($1.80)($1.50)+$0.30($0.05)$0.31 million$0.18 million11/10/2022Q2 2023($2.40)($2.40)-($0.08)$0.31 million($0.89) million8/11/2022Q1 2023($2.70)($3.00)($0.30)($0.10)$0.34 million$0.31 million Get the Latest News and Ratings for VTGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vistagen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 6/23/2022Q4 2022($1.80)($2.40)($0.60)($0.08)$0.33 million$0.04 million 2/10/2022Q3 2022($2.40)($1.50)+$0.90($0.05)$0.33 million$0.36 million 11/10/2021Q3 2021($1.50)($2.10)($0.60)($0.07)$0.33 million$0.36 million 8/12/2021Q2 2021($1.50)($1.20)+$0.30($0.04)$0.37 million$0.35 million 6/28/2021Q1 2021($1.50)($6.00)($4.50)($0.20)$0.31 million$0.44 million 2/11/2021Q4 2020($1.50)($2.10)($0.60)($0.07)$0.33 million$0.31 million11/12/2020Q3 2020($0.60)($1.50)($0.90)($0.05)$5.00 million$0.33 million 8/13/2020Q1 2021($2.10)($2.10)-($0.07)--6/29/2020Q4($2.40)($2.10)+$0.30($0.13)--2/13/2020Q3 2020($2.10)($4.50)($2.40)($0.15)--11/7/2019Q2($4.05)($3.90)+$0.15($0.13)--8/16/2019Q1 2020-($4.50)($4.50)($0.15)--6/25/2019Q4 2019-($4.50)($4.50)($0.15)-- Vistagen Therapeutics Earnings - Frequently Asked Questions When is Vistagen Therapeutics's earnings date? Vistagen Therapeutics has confirmed that its next quarterly earnings data will be published on Tuesday, June 11th, 2024. Learn more on VTGN's earnings history. Did Vistagen Therapeutics beat their earnings estimates last quarter? In the previous quarter, Vistagen Therapeutics (NASDAQ:VTGN) reported $0.00 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.34) by $0.34. Learn more on analysts' earnings estimate vs. VTGN's actual earnings. How can I listen to Vistagen Therapeutics's earnings conference call? The conference call for Vistagen Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How much revenue does Vistagen Therapeutics generate each year? Vistagen Therapeutics (NASDAQ:VTGN) has a recorded annual revenue of $1.11 million. How much profit does Vistagen Therapeutics generate each year? Vistagen Therapeutics (NASDAQ:VTGN) has a recorded net income of -$59.25 million. VTGN has generated $0.00 earnings per share over the last four quarters. What is Vistagen Therapeutics's EPS forecast for next year? Vistagen Therapeutics's earnings are expected to decrease from ($1.56) per share to ($2.00) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Merrimack Pharmaceuticals Earnings Date Acelyrin Earnings Date Theravance Biopharma Earnings Date Precigen Earnings Date Contineum Therapeutics Earnings Date Biomea Fusion Earnings Date Terns Pharmaceuticals Earnings Date Verrica Pharmaceuticals Earnings Date Amarin Earnings Date Neoleukin Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:VTGN) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vistagen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vistagen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
